A research team led by Director Kim V. Narry at the Center for RNA Research within the Institute for Basic Science (IBS) has ...

For older adults, the flu vaccine could look a little different this year. Last week, the US Food and Drug Administration ...

Fact checked by Elizabeth GallKey takeawaysThe FDA approved mFLUSIVA, the first mRNA flu vaccine, for adults 50 and older.Clinical trials showed that mFLUSIVA was approximately 27% more effective than ...

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...

Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...

It's no mystery. History tells us that President Trump’s executive order calling for the MMR to be split into separate shots could do real harm.

The modern American anti-vaccine movement combines several different constituencies. Some activists oppose most or all vaccines; others accept childhood vaccines but oppose COVID-19 vaccination, ...

For the first time, the United States has an mRNA flu shot. The FDA has cleared Moderna’s mFlusiva for adults aged 50 and older, making it the first mRNA flu vaccine approved in the country. Adults ...

Spread the love“`html Imagine a world where a cancer diagnosis, while still devastating, doesn’t carry the same chilling ...

RNA technology is moving beyond vaccines to enable targeted gene-editing therapies and novel treatments for complex diseases, ...